The potential anxiolytic and anti-depressive activity of CMP1 was studied in the elevated plus-maze test and in the forced swimming test. Furthermore, CMP1 sedative activity was evaluated in pentobarbital treated animals; the effect of CMP1 on spontaneous motor activity (total locomotion) was also evaluated. Our data show that CMP1, at doses that did not affect locomotion, was able to induce anxiolytic and sedative, but not anti-depressive effects. In conclusion, our results represent first evidence for an anxiolytic activity of this diterpenoid from Salvia cinnabarina.
RomussiG, CiaralloG, BisioA, FontanaN, De SimoneF, De TommasiN, MascoloN, PintoL. (2001) A new diterpenoid with antispasmodic activity from Salvia cinnabarina. Planta Medica, 67, 153–155.
2.
BisioA, PaganoB, RomussiA, BrunoO, De TommasiN, RomussiG, MattiaCA. (2007) Relative stereochemistry of a diterpene from Salvia cinnabarina.Molecules, 12, 2279–2287
3.
CapassoR, IzzoAA, CapassoF, RomussiG, BisioA, MascoloN. (2004) A diterpenoid from Salvia cinnabarina inhibits mouse intestinal motility in vivo. Planta Medica, 70, 375–377.
4.
CapassoR, IzzoAA, RomussiG, CapassoF, De TommasiN, BisioA, MascoloN. (2004) A secoisopimarane diterpenoid from Salvia cinnabarina inhibits rat urinary bladder contractility in vitro. Planta Medica, 70, 185–188
5.
AlfieriA, MaioneF, BisioA, RomussiG, MascoloN, CicalaC. (2007) Effect of a diterpenoid from Salvia cinnabarina on arterial blood pressure in rats. Phytotherapy Research, 21, 690–692.
6.
RustaiyanA, MasoudiS, Tabatabaei-AnarakiM. (2007) Terpenoids from Iranian Salvia species. Natural Product Communications, 2, 1031–1042.
7.
ImanshahidiM, HosseinzadehH. (2006) The pharmacological effects of Salvia species on the central nervous system. Phytotherapy Research, 20, 427–437.
8.
BennettDA, AmrickCL. (1987) Home cage pretreatment with diazepam: effects on subsequent conflict testing and rotorod assessment. Journal of Pharmacology and Experimental Therapeutics, 242, 595–599.
9.
PellowS, ChopinPh, FileSE, BrileyM. (1985) Validation of open closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. Journal of Neuroscience Methods, 14, 149–167.
10.
ListerRG. (1987) The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology, 92, 180–185.
11.
MoraS, Diaz-VelizG, LungenstrassH, García-GonzálezM, Coto-MoralesT, PolettiC, De LimaTCM, Herrera-RuizM, TortorielloJ. (2005) Central nervous system activity of the hydroalcoholic extract of Casimiroa edulis in rats and mice. Journal of Ethnopharmacology, 97, 191–197.
12.
LuckiI. (1997) The forced swimming test as a model for core and component behavioral effects of antidepressant drugs. Behaviour Pharmacology, 8, 523–532.
13.
PorsoltRD, Le PichonM, JalfreM. (1977) Depression: a new animal model sensitive to antidepressant treatments. Nature, 266, 730–732.
14.
CryanJF, MarkouA, LuckiI. (2002) Assessing antidepressant activity in rodents: recent developments and future needs. Trends in Pharmacological Science, 23, 238–245.
15.
DewsPB (1953) The measurement of the influence of drugs on voluntary activity in mice. British Journal of Pharmacology, 8, 46–48.
